TY - JOUR T1 - Novel echocardiographic markers of elevated left ventricular filling pressure during diastolic stress testing JF - medRxiv DO - 10.1101/2020.12.16.20248175 SP - 2020.12.16.20248175 AU - Jan Verwerft AU - Frederik H. Verbrugge AU - Guido Claessen AU - Lieven Herbots AU - Paul Dendale AU - Andreas B. Gevaert Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/18/2020.12.16.20248175.abstract N2 - Aims Diastolic stress testing (DST) is recommended to confirm heart failure with preserved ejection fraction (HFpEF) in patients with exertional dyspnea, but algorithms lack sensitivity. We aimed to identify additional echocardiographic markers of elevated pulmonary arterial wedge pressure during exercise (exPAWP) in patients referred for DST.Methods and Results We analyzed 22 patients referred for exercise right heart catheterization with simultaneous echocardiography. We identified candidate parameters in patients with exPAWP ≥25 mmHg. Elevated exPAWP was present in 14 patients, and was best identified by peak septal systolic annular velocity on color Doppler (exS’, area under the receiver operating characteristic curve (AUC) 0.97, 95% confidence interval 0.92-1.0) and mean pulmonary artery pressure/cardiac output slope (mPAP/CO, AUC 0.88 [0.72-1.0]). We propose a three-step decision tree to identify patients with elevated exPAWP. Applying this decision tree to 376 patients in an independent non-invasive DST cohort showed that patients labeled as ‘high probability of HFpEF’ had reduced peak oxygen uptake (12.8 (10.5-15.9) mL/kg/min, p<.001 vs intermediate/low probability), high H2FPEF score (55 (44-75)%, p<.007 vs intermediate/low probability), and typical clinical characteristics. The amount of inconclusive DST decreased from 80% using current recommendations, to 29% using the decision tree.Conclusion In DST for suspected HFpEF, exS’ was the most accurate echocardiographic parameter to identify elevated PAWP. We propose a decision tree including exS’ and mPAP/CO for interpretation of DST. Application of this decision tree revealed typical HFpEF characteristics in patients labeled as high probability of HFpEF, and substantially reduced the amount of inconclusive results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementF.H.V. is supported by the Special Research Fund (BOF) of Hasselt University (BOF19PD04). G.C. is supported by the Frans Van De Werf Fund for Clinical Cardiovascular Research and the Mathilde Horlait-Dapsens Scholarship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study complies with the Declaration of Helsinki and was approved by the Ethical Committee of the Jessa Hospital. All patients provided informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is accessible for other researchers by request to the authors. ER -